These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27725116)

  • 1. Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway.
    Chen L; Zhang Y; Li D; Zhang N; Liu R; Han B; Wei C; Liu H; Xu X; Hao J
    J Neuroimmunol; 2016 Oct; 299():164-171. PubMed ID: 27725116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type.
    Li D; Wang C; Yao Y; Chen L; Liu G; Zhang R; Liu Q; Shi FD; Hao J
    FASEB J; 2016 Oct; 30(10):3388-3399. PubMed ID: 27342766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages.
    Han R; Gao J; Zhai H; Xiao J; Ding Y; Hao J
    Exp Neurol; 2016 Jun; 280():106-14. PubMed ID: 27063582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Ni L; Koeffler HP; Yokoyama A
    Exp Hematol; 2010 Aug; 38(8):666-76. PubMed ID: 20382200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxiracetam ameliorates cognitive deficits in vascular dementia rats by regulating the expression of neuronal apoptosis/autophagy-related genes associated with the activation of the Akt/mTOR signaling pathway.
    Xu J; Qi Q; Lv P; Dong Y; Jiang X; Liu Z
    Braz J Med Biol Res; 2019; 52(11):e8371. PubMed ID: 31721903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression.
    Russo E; Leo A; Crupi R; Aiello R; Lippiello P; Spiga R; Chimirri S; Citraro R; Cuzzocrea S; Constanti A; De Sarro G
    J Psychiatr Res; 2016 Jul; 78():1-10. PubMed ID: 27019134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
    Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
    Leung EY; Askarian-Amiri M; Finlay GJ; Rewcastle GW; Baguley BC
    PLoS One; 2015; 10(7):e0131400. PubMed ID: 26148118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular effects of the mTOR inhibitor everolimus.
    Saran U; Foti M; Dufour JF
    Clin Sci (Lond); 2015 Nov; 129(10):895-914. PubMed ID: 26330617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.
    Yang MT; Lin YC; Ho WH; Liu CL; Lee WT
    J Neuroinflammation; 2017 Jan; 14(1):15. PubMed ID: 28109197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury.
    Nikolaeva I; Crowell B; Valenziano J; Meaney D; D'Arcangelo G
    J Neurotrauma; 2016 Jan; 33(2):183-93. PubMed ID: 26122481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.
    Jiao Y; Li G; Li Q; Ali R; Qin L; Li W; Qyang Y; Greif DM; Geirsson A; Humphrey JD; Tellides G
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1657-1666. PubMed ID: 28751568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
    Mimoto R; Nihira NT; Hirooka S; Takeyama H; Yoshida K
    Cancer Lett; 2017 Jan; 384():27-38. PubMed ID: 27746162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
    Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components.
    Saxena A; Sampson JR
    Semin Cell Dev Biol; 2014 Dec; 36():140-6. PubMed ID: 25263008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin complex 2 signaling pathway regulates transient receptor potential cation channel 6 in podocytes.
    Ding F; Zhang X; Li X; Zhang Y; Li B; Ding J
    PLoS One; 2014; 9(11):e112972. PubMed ID: 25393730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mTORC1 pathway in intestinal tumorigenesis.
    Fujishita T; Aoki M; Taketo MM
    Cell Cycle; 2009 Nov; 8(22):3684-7. PubMed ID: 19855161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.